Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...

With the season of spring well underway, there is a bright and magical star to view in our Arizona skies in April. The star is known as Arcturus. Arcturus is an amazing example of a bright red-orange ...

An update from Arcturus Therapeutics ( (ARCT) ) is now available.

Earnings Call Insights: Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic ...

The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. In a brief ...

Face east around 9-9:30 p.m. in mid-April and you can't miss shimmering orange Arcturus, the brightest star in the constellation Bootes the Bear Guardian. Two fists to the lower left of Arcturus, look ...

Los Angeles County Department of Public Health confirmed three cases of the Arcturus strain with "observational data" suggesting that those infected may be likely to experience pink eye Alexis Jones ...

Arcturus' mRNA vaccine will be trying to break into a crowded market if it gets approved. Moderna was in the right place at the right time, and Arcturus isn't. Yet, Arcturus doesn't need to sell many ...